Find out if you qualify for one of the ORAL trials. Apply online or call 866-439-6626.

Know someone with RA? Send a link to tell them about the ORAL trials. Email a friend.

Information for Medical Professionals

Bookmark and Share

Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide. The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.

The ORAL trials are made up of six different clinical trials.


Eligible patients will receive study-related medical care, including visits with a rheumatologist, at no cost.

For more information about the ORAL trials, please visit If you are interested in becoming an investigator in the ORAL trial program, please email [email protected].

If you are an investigator in the ORAL trial program, additional resources are available to you online.